Viewing Study NCT00064051


Ignite Creation Date: 2025-12-24 @ 11:53 PM
Ignite Modification Date: 2026-04-05 @ 7:50 PM
Study NCT ID: NCT00064051
Status: COMPLETED
Last Update Posted: 2013-08-02
First Post: 2003-07-08
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: 3-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
Sponsor: Vion Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module